scholarly journals Fetal growth restriction and neonatal morbidity prediction: which growth standard to use?

2022 ◽  
Vol 226 (1) ◽  
pp. S39
Author(s):  
Daisy Leon-Martinez ◽  
Lisbet S. Lundsberg ◽  
Jun Zhang ◽  
Jennifer F. Culhane ◽  
Moeun Son ◽  
...  
2015 ◽  
Vol 212 (1) ◽  
pp. S109 ◽  
Author(s):  
Malgorzata Mlynarczyk ◽  
Suneet Chauhan ◽  
Hind Baydoun ◽  
Catherine Wilkes ◽  
Kimberly Earhart ◽  
...  

2014 ◽  
Vol 210 (1) ◽  
pp. S75
Author(s):  
Hector Mendez-Figueroa ◽  
Lindsay Maggio ◽  
Joshua Dahlke ◽  
Catherine Albright ◽  
Nina Ayala ◽  
...  

2021 ◽  
Author(s):  
Xinzhi Tu ◽  
Chun Duan ◽  
Bingying Lin ◽  
Kangfeng Li ◽  
Jie Gao ◽  
...  

Abstract Background Fetal growth restriction (FGR) is a major cause of fetal and neonatal morbidity and mortality. Since meconium microbiome is a critical component for the health of newborns, the aim of this study was to characterize the meconium microbiota in neonates with FGR compared with healthy controls. Methods To avoid bacteria contamination, all included neonates were delivered by elective C-section, with their samples collected in the operation room. We collected meconium samples from 14 neonates affected by FGR and 20 matched healthy newborns. The microbiome profiles were examined by using high-throughput 16S rRNA sequencing and analyzed with customized bioinformatics pipelines. Results The β-diversity analysis demonstrated that FGR neonates clustered together that was distinct from control subjects. A number of taxa were found to be significantly depleted (e.g., Chryseobacterium) or enriched (e.g., Asticcacaulis) in the FGR group. In addition, the coordination network between various intestinal bacteria was found to be altered in FGR neonates. Conclusions FGR neonates exhibited alterations in the composition and symbiosis of microbiome, which will contribute to a better understanding of the relationship between the gut microbiota and FGR.


Author(s):  
Yakubova D.I.

Objective of the study: Comprehensive assessment of risk factors, the implementation of which leads to FGR with early and late manifestation. To evaluate the results of the first prenatal screening: PAPP-A, B-hCG, made at 11-13 weeks. Materials and Methods: A retrospective study included 110 pregnant women. There were 48 pregnant women with early manifestation of fetal growth restriction, 62 pregnant women with late manifestation among them. Results of the study: The risk factors for the formation of the FGR are established. Statistically significant differences in the indicators between groups were not established in the analyses of structures of extragenital pathology. According to I prenatal screening, there were no statistical differences in levels (PAPP-A, b-hCG) in the early and late form of FGR.


Sign in / Sign up

Export Citation Format

Share Document